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Abstract 
Objectives: We investigated the effects of intravesical application of adenosine 5’-triphosphate 
(ATP) on bladder activity to elucidate the role of urothelial barrier function and ecto-adenosine 
triphosphatase (ecto-ATPase) activity in the ATP-mediated mechanism inducing detrusor 
overactivity.  
Methods: Continuous cystometry via an intravesical catheter inserted from the bladder dome 
was performed in conscious female rats.  
Results: ATP solutions adjusted to pH 6.0 did not elicit significant detrusor overactivity at a 
concentration of 60 mM while in bladders pretreated with protamine sulfate (10 mg/ml) to 
increase urothelial permeability, ATP solution (pH 6.0) induced detrusor overactivity by 
decreasing intercontraction intervals (ICI).  These irritant effects of ATP after protamine 
treatment were antagonized by P2X receptor antagonists, such as 
pyridoxal-5-phosphate-6-azophenyl-2’,4’-disulfonic acid (70 µmol/kg) and 2’,3’-O-(2,4,6, 
trinitrophenyl) adenosine 5’-triphosphate (30 µmol/kg), and these were also suppressed in rats 
pretreated with systemic capsaicin (125 mg/kg s.c.).  α,β-methylene ATP (5 mM, pH 6.0) or 
ATP (60 mM, pH6) following intravesical infusion of 
4,4’-diisothiocyanatostilbene-2,2’-disulfonic acid (5 mM, pH 6.0), an ecto-ATPase inhibitor, 
induced detrusor overactivity without protamine pretreatment, but the reductions in ICI was 
smaller compared with ATP after protamine treatment.  
Conclusions: Low permeability of bladder epithelium and ecto-ATPase activity can prevent 
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ATP activation of subepithelial P2X receptors to induce bladder overactivity.  Thus, enhanced 
penetration of endogenous ATP due to urothelial damage may contribute to urinary frequency 
and bladder pain in hypersensitive bladder disorders such as interstitial cystitis.  
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Introduction 
 Recent studies have demonstrated that ATP is also released from urothelial cells by 
mechanical stretch of the bladder, and that bladder epithelium obtained from patients or cats with 
interstitial cystitis (IC) can release higher amounts of ATP compared with controls1-4.  Mice 
lacking the P2X3 receptor subunit, which is normally localized in suburothelial afferent nerves, 
reportedly had bladder hyporeflexia5.  Thus, P2X purinergic receptor-mediated transduction 
mechanisms in bladder afferent pathways seem to play an important role in the control of bladder 
function under normal and pathological conditions such as IC. 
It was reported that ATP infused intravesically at concentrations ranging 0.1-10mM can 
induce detrusor overactivity through an activation of bladder afferent pathways6,7.  However, 
ATP produces a acidic solution (pH 3-4), and it is therefore possible that detrusor overactivity 
following acidic ATP solution can be induced not only by ATP-induced afferent sensitization, but 
also by activation of acid-sensitive receptors such as TRPV1 capsaicin receptors8 and/or by 
damaging the bladder epithelium that may enhance ATP penetration into the subepithelial layer.  
Thus, we sought to investigate in further detail the ATP-mediated mechanisms inducing 
detrusor overactivity using pH-adjusted ATP solution, especially focusing on epithelial barrier 
function and ecto-adenosine triphosphatase (ecto-ATPase) activity. 
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Materials and Methods 
Animals 
Female Sprague-Dawley rats (weighing 170-240 g) were used.  The protocol for this 
study complies with the Guide for the Care and Use of Laboratory Animals published by the 
National Institute of Laboratory Animal Resources, and was approved by the University of 
Pittsburgh Institutional Animal Care and Use Committee.  
Cystometry 
Under halothane anesthesia, a PE-10 polyethylene catheter (Clay Adams, Parsippany, 
NJ) was inserted into the right jugular vein, and the free end of catheter was tunneled 
subcutaneously to the back of the neck.  Then, a PE-50 catheter was inserted through the 
bladder dome and tightened by surgical suture.   Thereafter, rats were placed in restraining 
cages and allowed to recover from anesthesia for 2 hours.  The intravesical catheter was 
connected to a pressure transducer and a syringe pump for infusing solutions.   Phosphate 
buffered saline (PBS) was infused (0.04 ml/min) continuously into the bladder until the interval 
of micturition cycles became stable.  Then three micturition cycles were analyzed as baseline 
cystometric parameters.  Intercontraction intervals (ICI), maximal voiding pressure (MVP), 
pressure threshold for voiding (PT) and baseline pressure (BP) were measured.  
Drug administration 
In the first group of rats, ATP (Sigma Aldrich Co., St. Louis, MO) dissolved in PBS (60 
mM, n = 7), adjusted to pH 6.0 using sodium hydroxide, was infused intravesically following a 
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one hour intravesical instillation of PBS solution, which was also adjusted to pH 6.0, after a 
control period with normal PBS to examine whether pH-adjusted ATP solution can induce 
bladder overactivity.  
In the second group of rats, protamine sulfate (PS; Sigma) dissolved in PBS (10 mg/ml) 
was instilled into the bladder for one hour to increase the permeability of bladder epithelium9, 
and then PBS (pH 6.0) was infused one hour.  Thereafter, ATP (20, 40 and 60 mM, pH 6.0, n = 
7, respectively) was instilled intravesically.  P2X receptor antagonists, 
pyridoxal-5-phosphate-6-azophenyl-2’,4’-disulfonic acid (PPADS; 70 µmol/kg, n = 5) (Tocris 
Cookson Inc., Ballwin, MO) or 2’,3’-O-(2,4,6, trinitrophenyl) adenosine 5’-triphosphate, 
trisodium salt (TNP-ATP; 30 µmol/kg, n = 6) (Sigma) were injected intravenously five minutes 
before starting ATP (60 mM) infusion. 
The experiments using PS and ATP (60mM, pH 6.0) were also performed in rats 
pretreated with systemic capsaicin (n = 6).  Capsaicin (Sigma) was administered to rats in a 
solution (20 mg/ml) given subcutaneously in divided doses on 2 consecutive days: 25 and 50 
mg/kg on the first day and 50 mg/kg on the second day.  Four days after the first injection, 
cystometry was performed.  To evaluate the effectiveness of capsaicin pretreatment, an eye 
wipe test was performed. 
In the next series of experiments, the role of ecto-ATPase on the surface of bladder 
epithelium was evaluated using α,β-methyleneadenosine 5’-triphosphate (α,β-methylene ATP, 5 
mM, Sigma), more stable analog of ATP, adjusted to pH 6.0, which was infused intravesically 
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after PBS (pH 6.0) with or without pre-infusion of PS (n = 6 and 4, respectively).  In another 
group of rats, 4,4’-Diisothiocyanatostilbene-2,2’-disulfonic acid (DIDS, Sigma) dissolved in 
PBS (5 mM, pH 6.0) was instilled into the bladder for one hour to inhibit ecto-ATPase activity, 
followed by ATP (60 mM, pH 6.0) with DIDS (5 mM) solution (n = 6). 
In these experiments, micturition cycles from 10 to 30 minutes after starting intravesical 
infusion of ATP or α,β-methylene ATP were analyzed because detrusor overactivity was 
consistently observed during this period without apparent desensitization; whereas micturition 
cycles from 10 to 60 minutes after starting intravesical administration were measured for 
protamine sulfate, PBS (pH 6.0) and DIDS infusion. 
Statistics 
Results are given as mean ± SEM.  Student’s two-tailed t-test was used for 
comparisons of cystometric parameters before and after drug administration in the same animal.  
One-way ANOVA followed by Dunnett's multiple comparison test was used for comparisons of 
different dosages of ATP after PS infusion, and a parametric test (unpaired t-test) was used to test 
for differences in cystometric parameters between different protocol groups.  For all statistical 
tests, P < 0.05 was considered significant.           
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Results 
Effect of intravesical ATP adjusted to pH 6.0 
PBS (pH 6.0) alone infused into the bladder did not alter any cystometric parameters.  
Similarly, application of ATP solutions (60 mM) adjusted to pH 6.0 did not elicit significant 
detrusor overactivity (Table 1).  
Effect of ATP (pH 6.0) after PS infusion 
When PS was infused intravesically, bladder overactivity was observed as evidenced by 
decreased ICI (Figure 1A). Thus, following PS infusion, PBS (pH 6.0) was infused intravesically, 
which partially normalize the cystometric parameters.  Intravesical instillation of ATP (20, 40 
and 60 mM) after PS treatment induced detrusor overactivity evidenced by a dose-dependent 
reduction in ICI 5-10 minutes after starting infusion (Figure 1A, B).  At 60 mM of ATP, ICI was 
decreased to 52.3 ± 8.1%, PT was decreased and BP was increased significantly (Figure 1B, 
Table 1).  In addition, the ATP-induced reduction in ICI after PS treatment was significantly 
greater compared with the ICI changes after ATP infusion without PS infusion (Figure 1B, Table 
1).  
Effect of P2X receptor antagonist 
PPADS, given intravenously before ATP infusion, antagonized the ATP-induced ICI 
reduction (Figure 1B, Table 1).  ICI, MVP, PT and BP were not changed significantly, and the 
changes of ICI and PT were significantly smaller compared to those without the antagonist.  
However, 30 minutes after PPADS administration, ICI started gradually decreasing to reach the 
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similar level of those obtained without the antagonist.  Another purinergic receptor antagonist, 
TNP-ATP, also suppressed detrusor overactivity induced by intravesical ATP (Figure 1B, Table 
1).  Intravesical ATP application after TNP-ATP decreased ICI to 75.5 ± 5.2%, however, the 
changes were significantly smaller compared to those without the antagonist, and the changes of 
PT was also significantly smaller compared to those without the antagonist (Table 1). 
Effect of ATP in capsaicin pretreated rats 
In capsaicin-pretreated rats, intravesical infusion of ATP solution following PS tended to 
decrease ICI (85.5 ± 6.1% of control) and PT (Figure 1B, Table 1), but without statistical 
significance. However, these changes were significantly smaller when compared to the ICI and 
PT reductions in normal rats.  No responses were observed in the eye wiping test with capsaicin 
in these animals. 
Effect of intravesical α,β-methylene ATP (pH 6.0) with or without PS treatment 
α,β-methylene ATP induced a significant decrease in ICI without PS pre-infusion (ICI; 
86.9 ± 3.9%, Table 2), and after intravesical infusion of PS, α,β-methylene ATP induced greater 
bladder overactivity by reducing ICI to 70.5 ± 4.8% (Table 2), which was significantly different 
from the ICI reduction by α,β-methylene ATP without PS pre-infusion (Figure 2, Table 2). 
Effect of ATP after DIDS infusion 
When DIDS, an ecto-ATPase inhibitor, was infused intravesically, MVP increased 
significantly, but ICI did not change.  ATP solution with DIDS instilled intravesically after 
DIDS induced detrusor overactivity with a significant decrease in ICI to 84.0 ± 3.2% (Table 2).  
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This change of ICI was significantly greater than the change after ATP infusion without PS, but 
was significantly smaller than the ATP-induced ICI change seen after PS infusion (Figure 2). 
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Comment 
The bladder permeability barrier is located in the apical membrane of superficial layer 
of epithelial cells, so-called umbrella cells10.  Intravesical application of PS has been used to 
induce bladder epithelial injury9, which permeabilize the apical membranes of theurothelium9.  
Acetate, propionate, butyrate or succinate salts at pH 4.4 alters transepithelial permeability of the 
rabbit urothelium, but not at pH 5.011, and in our study, ATP (pH 6.0) alone did not induce 
significant detrusor overactivity.  It therefore seems likely that ATP in pH 6.0 solution cannot 
penetrate the intact bladder epithelial layer, and that increased permeability of bladder epithelium 
is needed for ATP to activate suburothelial afferent nerves.  However, in previous studies, ATP 
infused intravesically at concentrations ranging 0.1-10mM induced detrusor overactivity6,7.  
Although the pH of ATP solutions was not described in these studies, ATP produces a very acidic 
solution ranging pH 3-4.  Therefore, it is possible that acidic ATP solution can induce detrusor 
overactivity not only by ATP-induced afferent sensitization, but also by activation of 
acid-sensitive receptors and/or increased ATP penetration into the subepithelial layer due to the 
damage of the bladder epithelium or the increased amount of uncharged ATP in the acidic 
solution.  
On the other hand, α,β-methylene ATP induced detrusor overactivity without PS 
treatment in our and other studies6.  This may be explained by the difference of stability of ATP 
and α,β-methylene ATP.  It has been reported that, in the extracellular space of the urothelium 
and smooth muscles, including detrusor, ATP is broken down by ecto-ATPase12, but, in the 
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guinea-pig urinary bladder, the rate of degradation of α,β-methylene ATP by ecto-ATPase is less 
than 25% compared with ATP12.  In our study, when DIDS, an inhibitor of ecto-ATPase13, was 
infused intravesically, the following application of ATP (pH 6.0) induced detrusor overactivity 
without pre-infusion of PS.  Rong et al. also showed that intravesical application of 
α,β-methylene ATP increased multifiber discharges in the mouse bladder, suggesting that 
α,β-methylene ATP can penetrate the urothelium14.  Taken together, it is assumed that ATP (pH 
6.0) with co-application of DIDS or α,β-methylene ATP can penetrate bladder epithelium to 
induce detrusor overactivity without changing urothelial permeability and that, in addition to 
urothelial barrier function, ecto-ATPase activity in the urothelium also contributes to the 
suppression of ATP-induced detrusor overactivity.   In addition, since DIDS is also known to be 
an inhibitor of Cl- transport15, it is possible that DIDS-induced Cl- transport inhibition might 
increase sensitization of C-fiber bladder afferents by ATP although further studies are needed to 
clarify this point.   
In the rat, bladder sensory neurons express homomeric P2X3 and heteromeric P2X2/3 
receptors16, and P2X3 staining has been detected in suburothelial afferent nerves of the wall of 
bladder and ureter17.  Deletion of the P2X3 gene results in urinary bladder hyporeflexia 
evidenced by increased voiding volume18 and decreased bladder afferent sensitivity in response 
to increasing intravesical pressure5.  Furthermore, deletion of the P2X2 gene, and loss of 
heteromeric P2X2/3 receptors, also results in a marked urinary bladder hyporeflexia due to 
increased thresholds for bladder contractions during bladder filling19.  King et al. reported that, 
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the P2X3 receptor blockade raised pressure and volume thresholds for the micturition reflex, 
whereas the P2X1 receptor blockade diminished motor activity associated with voiding20.  In 
our study, intravesical infusion of ATP after PS induced detrusor overactivity characterized by 
reductions in ICI and PT, but not MVP, which were antagonized by PPADS and TNP-ATP.  
PPADS is a selective P2X receptor antagonist21, and TNP-ATP has been demonstrated to be a 
potent nanomolar antagonist for the recombinant rat P2X1, P2X2/3 and P2X3 receptors22.  Overall, 
these data are likely to indicate that intravesical application of ATP after PS treatment activated 
P2X3 and P2X2/3 receptors located on subepithelial nerve fibers which induce the reduction in ICI 
and PT although there is also the possibility that intravesical ATP may have its effects through 
stimulating the urothelial cells and increasing urothelial release of various mediators to indirectly 
activate subepithelial sensory nerves.  
Afferent pathways innervating the rat urinary bladder consist of myelinated Aδ-fibers 
and unmyelinated C-fibers23, and the majority of C-fiber bladder afferent neurons are capsaicin 
sensitive24.  Yiangou et al. have also demonstrated the presence of TRPV1-IR and P2X3-IR 
nerve fibers in rat bladder suburothelium25.  In the present study, the reduction of ICI after 
intravesical ATP infusion in capsaicin-pretreated rats was significantly smaller compared with 
normal rats, indicating that the majority of P2X3 and/or P2X2/3 receptors activated by intravesical 
ATP are located on capsaicin-sensitive C-fiber afferents.   
 Recent studies demonstrated that bladder epithelium obtained from patients with IC can 
release higher amounts of ATP during stretch3.  In addition, increased urothelial permeability 
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due to urothelial damage has been documented to be an important mechanism for inducing 
painful symptoms in IC26.  It has also been reported that detrusor smooth muscles from patients 
with unstable or obstructed bladders had lower ATPase activity than stable bladders27.  Thus, 
the damage of urothelial barrier function and/or decreased levels of ecto-ATPase activity could 
contribute to C-fiber desensitization by endogenous ATP released from bladder epithelium in 
patients with IC or bladder overactivity.  
Conclusions 
Intravesically applied ATP in pH 6.0 solution does not penetrate the intact bladder 
epithelial layer in the rat because of permeability barrier and ecto-ATPase of the urothelium.  
Therefore, increased permeability of bladder epithelium is needed for exogenously applied ATP 
to activate subepithelial P2X receptors in order to sensitize C-fiber afferents and induce detrusor 
overactivity. 
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Legends 
 
Figure 1: Effects of sequential intravesical application of PBS (pH 7.4), protamine sulfate (10 
mg/ml), PBS (pH 6.0) and ATP (60 mM, pH 6.0) on bladder activity in conscious normal rats (A).  
Effects of intravesical instillation of ATP (60 mM without protamine sulfate pre-infusion, and 20, 
40, 60 mM with protamine sulfate pre-infusion, and 60 mM with protamine sulfate after PPADS 
or TNP-ATP intravenous injection) on ICI expressed as % of the value during PBS (pH 6.0) 
infusion after protamine treatment in conscious normal and capsaicin pretreated rats (B).  n = 7 
(without protamine sulfate), n = 7 (20, 40, 60 mM), n = 5 (60 mM after PPADS i.v.), n = 6 
(60mM after TNP-ATP i.v.), n = 6 (capsaicin pretreated rats).  PS; protamine sulfate 
pre-infusion. 
* P < 0.01, ** P < 0.05 (unpaired t-test), †P < 0.01 (Dunnett’s multiple comparison test) 
 
Figure 2: Comparison of the effects of intravesical instillation of ATP (60 mM, pH 6.0) with or 
without protamine sulfate (PS, 10 mg/ml) or DIDS (5 mM) (left), and the effects of 
α,β-methylene ATP (5 mM, pH 6.0) with or without protamine sulfate (right) on ICI under 
different conditions in conscious normal rats.  Data are expressed as % of the value during PBS 
(pH 6.0) infusion.  PS; protamine sulfate pre-infusion.  Presence and absence of the 
pre-treatment with PS or DIDS are indicated by plus (+) and minus (-), respectively. 
* P < 0.01, ** P < 0.05 (unpaired t-test) 
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* P < 0.01, ** P < 0.05 (unpaired t-test), †P < 0.01 (Dunnett’s multiple comparison test) 
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